Bevacizumab local complications

Ophthalmology. 2009 Nov;116(11):2264.e1-3. doi: 10.1016/j.ophtha.2009.07.027.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Angiogenesis Inhibitors / administration & dosage
  • Angiogenesis Inhibitors / adverse effects*
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Choroidal Neovascularization / drug therapy
  • Diabetic Retinopathy / drug therapy
  • Eye Diseases / chemically induced*
  • Eye Diseases / diagnosis
  • Female
  • Fluorescein Angiography
  • Humans
  • Injections
  • Macular Degeneration / drug therapy
  • Macular Edema / drug therapy
  • Male
  • Middle Aged
  • Ultrasonography
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Vitreous Body
  • Young Adult

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Vascular Endothelial Growth Factor A
  • Bevacizumab